CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-14 | Herrmann John A III EVP, Chief Legal Officer | Shares withheld for taxes | −700 | $5.69 | $4K | 13,233 |
| 2023-12-14 | Herrmann John A III EVP, Chief Legal Officer | Option exercise · Restricted Stock Units | −2,100 | 0 | ||
| 2023-12-14 | Dubovsky Filip President, R&D | Option exercise | +2,833 | $5.69 | $16K | 55,150 |
| 2023-12-14 | Dubovsky Filip President, R&D | Shares withheld for taxes | −1,368 | $5.69 | $8K | 53,782 |
| 2023-12-14 | Dubovsky Filip President, R&D | Option exercise · Restricted Stock Units | −2,833 | 0 | ||
| 2023-12-11 | Casey Mark J EVP, Chief Legal Officer | Grant or award · Stock Options (Right to buy) | +144,694 | 144,694 | ||
| 2023-12-11 | Casey Mark J EVP, Chief Legal Officer | Grant or award · Restricted Stock Units | +125,698 | 125,698 | ||
| 2023-11-05 | Dubovsky Filip President, R&D | Option exercise | +1,400 | $7.06 | $10K | 52,994 |
| 2023-11-05 | Dubovsky Filip President, R&D | Shares withheld for taxes | −677 | $7.06 | $5K | 52,317 |
| 2023-11-05 | Dubovsky Filip President, R&D | Option exercise · Restricted Stock Units | −1,400 | 0 | ||
| 2023-10-29 | Rodgers Richard J Director | Option exercise | +3,800 | 3,800 | ||
| 2023-10-29 | Rodgers Richard J Director | Option exercise · Restricted Stock Units | −3,800 | 7,600 | ||
| 2023-09-16 | Dubovsky Filip President, R&D | Option exercise | +12,644 | $7.71 | $97K | 57,702 |
| 2023-09-16 | Dubovsky Filip President, R&D | Shares withheld for taxes | −6,108 | $7.71 | $47K | 51,594 |
| 2023-09-16 | Dubovsky Filip President, R&D | Option exercise · Restricted Stock Units | −12,644 | 0 | ||
| 2023-09-12 | Kelly James Patrick EVP, CFO and Treasurer | Grant or award · Restricted Stock Units | −35,000 | 35,000 | ||
| 2023-08-19 | Trizzino John EVP, CCO and CBO | Option exercise | +655 | 10,145 | ||
| 2023-08-19 | Trizzino John EVP, CCO and CBO | Shares withheld for taxes | −317 | $7.14 | $2K | 9,828 |
| 2023-08-19 | Trizzino John EVP, CCO and CBO | Option exercise · Restricted Stock Units | −655 | 655 |
Page 14 of 14 · 279 trades